As of 2026-06-22, the Fair Value of Beam Therapeutics Inc (BEAM) is -3.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 34.14 USD, the upside of Beam Therapeutics Inc is -109.26%.
With the market price of 34.14 USD and our fair value calculation, Beam Therapeutics Inc (BEAM) is not a good investment. Investing in BEAM stocks now will result in a potential loss of 109.26%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -370.64 | -289.09 | -132.53 | -376.74 | -79.99 | -249.80 |
| YoY growth | -90.47% | 22.00% | 54.16% | -184.28% | 78.77% | -23.96% |
| Market Cap (mil) | 3,512.32 |
| P/E | |
| Forward P/E |
| EPS | -0.63 |
| Avg earnings growth rate | -23.96% |
| TTM earnings | -65.04 |